Loading…
Heightened innate immune state induced by viral vector leads to enhanced response to challenge and prolongs malaria vaccine protection
Cytomegalovirus is a promising vaccine vector; however, mechanisms promoting CD4 T cell responses to challenge, by CMV as a vector, are unknown. The ability of MCMV to prolong immunity generated by short-lived malaria vaccine was tested. MCMV provided non-specific protection to challenge with Plasmo...
Saved in:
Published in: | iScience 2024-12, Vol.27 (12), p.111468, Article 111468 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c347t-baefd4db38a1c9cdb9d3903295741099c485d051160dc730dfd13b33a88781703 |
container_end_page | |
container_issue | 12 |
container_start_page | 111468 |
container_title | iScience |
container_volume | 27 |
creator | Gbedande, Komi Ibitokou, Samad A. Endrino, Mark Joseph D. Yap, George S. Brown, Michael G. Stephens, Robin |
description | Cytomegalovirus is a promising vaccine vector; however, mechanisms promoting CD4 T cell responses to challenge, by CMV as a vector, are unknown. The ability of MCMV to prolong immunity generated by short-lived malaria vaccine was tested. MCMV provided non-specific protection to challenge with Plasmodium and increased interleukin-12 (IL-12) and CD8α+ dendritic cell (DC) numbers through prolonged MCMV-dependent interferon gamma (IFN-γ) production. This late innate response to MCMV increased IL-12 upon challenge and increased the polyclonal CD4 effector T cell response to Plasmodium, protecting in an IL-12-dependent manner. Although Plasmodium-vaccine-induced protection decayed by d200, MCMV restored protection through IFN-γ. Mechanistically, protection depended on MCMV-induced-IFN-γ increasing CD8α+ DCs and IL-12p40. MCMV expressing a Plasmodium epitope increased parasite-specific CD4 effector and effector memory T cells persisting after malaria vaccination, both phenotypes reported to protect. Overall, enhanced innate cell status, a mechanism of heterologous protection by MCMV, led to a stronger T cell response to challenge.
[Display omitted]
•MCMV-B5 vector maintains specific CD4 T cells and effector memory phenotype•IFN-γ from persistent MCMV increases CD8α+ DCs, IL-12, and effector T cell response•Neutralization of IL-12 during challenge limits MCMV-based protection•MCMV-induced innate immune state improves T cell response to Plasmodium challenge
Natural sciences; Biological sciences; Immunology; Immune response; Microbiology; Viral microbiology |
doi_str_mv | 10.1016/j.isci.2024.111468 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_bf136090a4f9463abd7179b214406067</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2589004224026956</els_id><doaj_id>oai_doaj_org_article_bf136090a4f9463abd7179b214406067</doaj_id><sourcerecordid>3151879622</sourcerecordid><originalsourceid>FETCH-LOGICAL-c347t-baefd4db38a1c9cdb9d3903295741099c485d051160dc730dfd13b33a88781703</originalsourceid><addsrcrecordid>eNp9kc9q3DAQxk1paUKaF-ih6NjLbvXPlgW9lNA2gUAv7VmMpfGuFlnaSt6FvECfO3Kchp4KAkkz33zDzK9p3jO6ZZR1nw5bX6zfcsrlljEmu_5Vc8nbXm8olfz1P--L5rqUA6WU1yN197a5EFrVrBaXzZ9b9Lv9jBEd8THCjMRP0ykiKfPTJ7qTrbnhgZx9hkDOaOeUSUBwhcyJYNxDXBQZyzHFgkvQ7iEEjDskEB055hRS3BUyQYDsgZzBWl9b1MRc7XyK75o3I4SC18_3VfPr29efN7eb-x_f726-3G-skGreDICjk24QPTCrrRu0E5oKrlslGdXayr51tGWso84qQd3omBiEgL5XPVNUXDV3q69LcDDH7CfIDyaBN0-BlHcG8uxtQDOMTHRUU5Cjlp2AwSmm9MCZlLSjnapeH1evOsbvE5bZTBUJhgAR06kYwVrWK91xXqV8ldqcSsk4vrRm1Cw4zcEsOM2C06w4a9GHZ__TMKF7KfkLrwo-rwKsGzt7zKZa4ALD57rWOpL_n_8j2Xexcg</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3151879622</pqid></control><display><type>article</type><title>Heightened innate immune state induced by viral vector leads to enhanced response to challenge and prolongs malaria vaccine protection</title><source>ScienceDirect Journals</source><source>PubMed Central</source><creator>Gbedande, Komi ; Ibitokou, Samad A. ; Endrino, Mark Joseph D. ; Yap, George S. ; Brown, Michael G. ; Stephens, Robin</creator><creatorcontrib>Gbedande, Komi ; Ibitokou, Samad A. ; Endrino, Mark Joseph D. ; Yap, George S. ; Brown, Michael G. ; Stephens, Robin</creatorcontrib><description>Cytomegalovirus is a promising vaccine vector; however, mechanisms promoting CD4 T cell responses to challenge, by CMV as a vector, are unknown. The ability of MCMV to prolong immunity generated by short-lived malaria vaccine was tested. MCMV provided non-specific protection to challenge with Plasmodium and increased interleukin-12 (IL-12) and CD8α+ dendritic cell (DC) numbers through prolonged MCMV-dependent interferon gamma (IFN-γ) production. This late innate response to MCMV increased IL-12 upon challenge and increased the polyclonal CD4 effector T cell response to Plasmodium, protecting in an IL-12-dependent manner. Although Plasmodium-vaccine-induced protection decayed by d200, MCMV restored protection through IFN-γ. Mechanistically, protection depended on MCMV-induced-IFN-γ increasing CD8α+ DCs and IL-12p40. MCMV expressing a Plasmodium epitope increased parasite-specific CD4 effector and effector memory T cells persisting after malaria vaccination, both phenotypes reported to protect. Overall, enhanced innate cell status, a mechanism of heterologous protection by MCMV, led to a stronger T cell response to challenge.
[Display omitted]
•MCMV-B5 vector maintains specific CD4 T cells and effector memory phenotype•IFN-γ from persistent MCMV increases CD8α+ DCs, IL-12, and effector T cell response•Neutralization of IL-12 during challenge limits MCMV-based protection•MCMV-induced innate immune state improves T cell response to Plasmodium challenge
Natural sciences; Biological sciences; Immunology; Immune response; Microbiology; Viral microbiology</description><identifier>ISSN: 2589-0042</identifier><identifier>EISSN: 2589-0042</identifier><identifier>DOI: 10.1016/j.isci.2024.111468</identifier><identifier>PMID: 39758993</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Biological sciences ; Immune response ; Immunology ; Microbiology ; Natural sciences ; Viral microbiology</subject><ispartof>iScience, 2024-12, Vol.27 (12), p.111468, Article 111468</ispartof><rights>2024 The Authors</rights><rights>2024 The Authors.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c347t-baefd4db38a1c9cdb9d3903295741099c485d051160dc730dfd13b33a88781703</cites><orcidid>0000-0002-3229-5566 ; 0000-0001-8036-600X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S2589004224026956$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3535,27903,27904,45759</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39758993$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gbedande, Komi</creatorcontrib><creatorcontrib>Ibitokou, Samad A.</creatorcontrib><creatorcontrib>Endrino, Mark Joseph D.</creatorcontrib><creatorcontrib>Yap, George S.</creatorcontrib><creatorcontrib>Brown, Michael G.</creatorcontrib><creatorcontrib>Stephens, Robin</creatorcontrib><title>Heightened innate immune state induced by viral vector leads to enhanced response to challenge and prolongs malaria vaccine protection</title><title>iScience</title><addtitle>iScience</addtitle><description>Cytomegalovirus is a promising vaccine vector; however, mechanisms promoting CD4 T cell responses to challenge, by CMV as a vector, are unknown. The ability of MCMV to prolong immunity generated by short-lived malaria vaccine was tested. MCMV provided non-specific protection to challenge with Plasmodium and increased interleukin-12 (IL-12) and CD8α+ dendritic cell (DC) numbers through prolonged MCMV-dependent interferon gamma (IFN-γ) production. This late innate response to MCMV increased IL-12 upon challenge and increased the polyclonal CD4 effector T cell response to Plasmodium, protecting in an IL-12-dependent manner. Although Plasmodium-vaccine-induced protection decayed by d200, MCMV restored protection through IFN-γ. Mechanistically, protection depended on MCMV-induced-IFN-γ increasing CD8α+ DCs and IL-12p40. MCMV expressing a Plasmodium epitope increased parasite-specific CD4 effector and effector memory T cells persisting after malaria vaccination, both phenotypes reported to protect. Overall, enhanced innate cell status, a mechanism of heterologous protection by MCMV, led to a stronger T cell response to challenge.
[Display omitted]
•MCMV-B5 vector maintains specific CD4 T cells and effector memory phenotype•IFN-γ from persistent MCMV increases CD8α+ DCs, IL-12, and effector T cell response•Neutralization of IL-12 during challenge limits MCMV-based protection•MCMV-induced innate immune state improves T cell response to Plasmodium challenge
Natural sciences; Biological sciences; Immunology; Immune response; Microbiology; Viral microbiology</description><subject>Biological sciences</subject><subject>Immune response</subject><subject>Immunology</subject><subject>Microbiology</subject><subject>Natural sciences</subject><subject>Viral microbiology</subject><issn>2589-0042</issn><issn>2589-0042</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNp9kc9q3DAQxk1paUKaF-ih6NjLbvXPlgW9lNA2gUAv7VmMpfGuFlnaSt6FvECfO3Kchp4KAkkz33zDzK9p3jO6ZZR1nw5bX6zfcsrlljEmu_5Vc8nbXm8olfz1P--L5rqUA6WU1yN197a5EFrVrBaXzZ9b9Lv9jBEd8THCjMRP0ykiKfPTJ7qTrbnhgZx9hkDOaOeUSUBwhcyJYNxDXBQZyzHFgkvQ7iEEjDskEB055hRS3BUyQYDsgZzBWl9b1MRc7XyK75o3I4SC18_3VfPr29efN7eb-x_f726-3G-skGreDICjk24QPTCrrRu0E5oKrlslGdXayr51tGWso84qQd3omBiEgL5XPVNUXDV3q69LcDDH7CfIDyaBN0-BlHcG8uxtQDOMTHRUU5Cjlp2AwSmm9MCZlLSjnapeH1evOsbvE5bZTBUJhgAR06kYwVrWK91xXqV8ldqcSsk4vrRm1Cw4zcEsOM2C06w4a9GHZ__TMKF7KfkLrwo-rwKsGzt7zKZa4ALD57rWOpL_n_8j2Xexcg</recordid><startdate>20241220</startdate><enddate>20241220</enddate><creator>Gbedande, Komi</creator><creator>Ibitokou, Samad A.</creator><creator>Endrino, Mark Joseph D.</creator><creator>Yap, George S.</creator><creator>Brown, Michael G.</creator><creator>Stephens, Robin</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-3229-5566</orcidid><orcidid>https://orcid.org/0000-0001-8036-600X</orcidid></search><sort><creationdate>20241220</creationdate><title>Heightened innate immune state induced by viral vector leads to enhanced response to challenge and prolongs malaria vaccine protection</title><author>Gbedande, Komi ; Ibitokou, Samad A. ; Endrino, Mark Joseph D. ; Yap, George S. ; Brown, Michael G. ; Stephens, Robin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c347t-baefd4db38a1c9cdb9d3903295741099c485d051160dc730dfd13b33a88781703</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Biological sciences</topic><topic>Immune response</topic><topic>Immunology</topic><topic>Microbiology</topic><topic>Natural sciences</topic><topic>Viral microbiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gbedande, Komi</creatorcontrib><creatorcontrib>Ibitokou, Samad A.</creatorcontrib><creatorcontrib>Endrino, Mark Joseph D.</creatorcontrib><creatorcontrib>Yap, George S.</creatorcontrib><creatorcontrib>Brown, Michael G.</creatorcontrib><creatorcontrib>Stephens, Robin</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>iScience</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gbedande, Komi</au><au>Ibitokou, Samad A.</au><au>Endrino, Mark Joseph D.</au><au>Yap, George S.</au><au>Brown, Michael G.</au><au>Stephens, Robin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Heightened innate immune state induced by viral vector leads to enhanced response to challenge and prolongs malaria vaccine protection</atitle><jtitle>iScience</jtitle><addtitle>iScience</addtitle><date>2024-12-20</date><risdate>2024</risdate><volume>27</volume><issue>12</issue><spage>111468</spage><pages>111468-</pages><artnum>111468</artnum><issn>2589-0042</issn><eissn>2589-0042</eissn><abstract>Cytomegalovirus is a promising vaccine vector; however, mechanisms promoting CD4 T cell responses to challenge, by CMV as a vector, are unknown. The ability of MCMV to prolong immunity generated by short-lived malaria vaccine was tested. MCMV provided non-specific protection to challenge with Plasmodium and increased interleukin-12 (IL-12) and CD8α+ dendritic cell (DC) numbers through prolonged MCMV-dependent interferon gamma (IFN-γ) production. This late innate response to MCMV increased IL-12 upon challenge and increased the polyclonal CD4 effector T cell response to Plasmodium, protecting in an IL-12-dependent manner. Although Plasmodium-vaccine-induced protection decayed by d200, MCMV restored protection through IFN-γ. Mechanistically, protection depended on MCMV-induced-IFN-γ increasing CD8α+ DCs and IL-12p40. MCMV expressing a Plasmodium epitope increased parasite-specific CD4 effector and effector memory T cells persisting after malaria vaccination, both phenotypes reported to protect. Overall, enhanced innate cell status, a mechanism of heterologous protection by MCMV, led to a stronger T cell response to challenge.
[Display omitted]
•MCMV-B5 vector maintains specific CD4 T cells and effector memory phenotype•IFN-γ from persistent MCMV increases CD8α+ DCs, IL-12, and effector T cell response•Neutralization of IL-12 during challenge limits MCMV-based protection•MCMV-induced innate immune state improves T cell response to Plasmodium challenge
Natural sciences; Biological sciences; Immunology; Immune response; Microbiology; Viral microbiology</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>39758993</pmid><doi>10.1016/j.isci.2024.111468</doi><orcidid>https://orcid.org/0000-0002-3229-5566</orcidid><orcidid>https://orcid.org/0000-0001-8036-600X</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2589-0042 |
ispartof | iScience, 2024-12, Vol.27 (12), p.111468, Article 111468 |
issn | 2589-0042 2589-0042 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_bf136090a4f9463abd7179b214406067 |
source | ScienceDirect Journals; PubMed Central |
subjects | Biological sciences Immune response Immunology Microbiology Natural sciences Viral microbiology |
title | Heightened innate immune state induced by viral vector leads to enhanced response to challenge and prolongs malaria vaccine protection |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T17%3A45%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Heightened%20innate%20immune%20state%20induced%20by%20viral%20vector%20leads%20to%20enhanced%20response%20to%20challenge%20and%20prolongs%20malaria%20vaccine%20protection&rft.jtitle=iScience&rft.au=Gbedande,%20Komi&rft.date=2024-12-20&rft.volume=27&rft.issue=12&rft.spage=111468&rft.pages=111468-&rft.artnum=111468&rft.issn=2589-0042&rft.eissn=2589-0042&rft_id=info:doi/10.1016/j.isci.2024.111468&rft_dat=%3Cproquest_doaj_%3E3151879622%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c347t-baefd4db38a1c9cdb9d3903295741099c485d051160dc730dfd13b33a88781703%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3151879622&rft_id=info:pmid/39758993&rfr_iscdi=true |